Skip to Main content Skip to Navigation
Journal articles

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.

Jacqueline Trouillas 1, * Pascal Roy 2 Nathalie Sturm Emmanuelle Dantony 2 Christine Cortet-Rudelli Gabriel Viennet 3 Jean-François Bonneville Richard Assaker Carole Auger 4 Thierry Brue 5 Aurélie Cornelius Henry Dufour Emmanuel Jouanneau Patrick François Françoise Galland 6 François Mougel 7 François Chapuis 8 Laurent Villeneuve 8 Claude-Alain Maurage 9 Dominique Figarella-Branger 10 Gérald Raverot * Anne Barlier M. Bernier Fabrice Bonnet 11, 12 F. Borson-Chazot Gilles Brassier 13 S. Caulet-Maugendre 14 O. Chabre P. Chanson J. F. Cottier B. Delemer E. Delgrange L. Di Tommaso S. Eimer Sophie Gaillard M. Jan J. J. Girard V. Lapras H. Loiseau J. G. Passagia M. Patey A. Penfornis J. Y. Poirier G. Perrin A. Tabarin
Abstract : Pituitary adenomas are currently classified by histological, immunocytochemical and numerous ultrastructural characteristics lacking unequivocal prognostic correlations. We investigated the prognostic value of a new clinicopathological classification with grades based on invasion and proliferation. This retrospective multicentric case-control study comprised 410 patients who had surgery for a pituitary tumour with long-term follow-up. Using pituitary magnetic resonance imaging for diagnosis of cavernous or sphenoid sinus invasion, immunocytochemistry, markers of the cell cycle (Ki-67, mitoses) and p53, tumours were classified according to size (micro, macro and giant), type (PRL, GH, FSH/LH, ACTH and TSH) and grade (grade 1a: non-invasive, 1b: non-invasive and proliferative, 2a: invasive, 2b: invasive and proliferative, and 3: metastatic). The association between patient status at 8-year follow-up and age, sex, and classification was evaluated by two multivariate analyses assessing disease- or recurrence/progression-free status. At 8 years after surgery, 195 patients were disease-free (controls) and 215 patients were not (cases). In 125 of the cases the tumours had recurred or progressed. Analyses of disease-free and recurrence/progression-free status revealed the significant prognostic value (p < 0.001; p < 0.05) of age, tumour type, and grade across all tumour types and for each tumour type. Invasive and proliferative tumours (grade 2b) had a poor prognosis with an increased probability of tumour persistence or progression of 25- or 12-fold, respectively, as compared to non-invasive tumours (grade 1a). This new, easy to use clinicopathological classification of pituitary endocrine tumours has demonstrated its prognostic worth by strongly predicting the probability of post-operative complete remission or tumour progression and so could help clinicians choose the best post-operative therapy.
Complete list of metadata
Contributor : Morgane Le Corre Connect in order to contact the contributor
Submitted on : Tuesday, October 22, 2013 - 3:41:20 PM
Last modification on : Wednesday, October 20, 2021 - 3:19:22 AM

Links full text




Jacqueline Trouillas, Pascal Roy, Nathalie Sturm, Emmanuelle Dantony, Christine Cortet-Rudelli, et al.. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.. Acta Neuropathologica, Springer Verlag, 2013, 126 (1), pp.123-35. ⟨10.1007/s00401-013-1084-y⟩. ⟨hal-00875723⟩



Record views